NRSN Neurosense Therapeutics Ltd
Company Analysis
Latest News
🟢 Neurosense Therapeutics is trading 11.18% up today amid biotech optimism around AI-enabled drug discovery
Neurosense Therapeutics is trading at $7.36 (+11.18%) mainly amid a broader biotech-sector rally. - No new company-specific announcement clearly explains the...
🟢 Neurosense Therapeutics is trading 5.29% up today without a clear catalyst
Neurosense Therapeutics is trading 5.29% up at $6.97 after closing at $6.62 on September 21, 2026; no new company-specific announcement clearly explains the...
🟢 Neurosense Therapeutics is trading 7.2% up today on broader market strength
Neurosense Therapeutics is trading 7.2% up at $6.81, supported by stronger broader markets. - The move follows a 5.51% decline to $6.35 on September 18. -...
🟢 Neurosense Therapeutics is trading 8% up in pre-market as S&P 500 and NASDAQ Composite rise
Neurosense Therapeutics is trading at $6.86, up 8.03% in pre-market with the move best attributed to broad risk-on sentiment. - S&P 500 is up 0.65% and NASDAQ...
🟢 Neurosense Therapeutics is trading 13.37% up today amid a broader biotechnology rally
Neurosense Therapeutics is trading 13.37% up at $6.91, amid a broader risk-on session lifting biotechnology stocks. - Major U.S. indexes are higher as...
🟢 Neurosense Therapeutics is trading 6.6% up today amid stronger market and biotech gains
Neurosense Therapeutics is trading 6.6% up now at $6.50, supported primarily by stronger market sentiment and advancing biotechnology stocks. - No new...
🟢 Neurosense Therapeutics is trading 5% up in pre-market as U.S. futures point higher
Neurosense Therapeutics is trading 5% up at $6.40 as U.S. futures point to a firmer pre-market tone. - S&P 500, Nasdaq Composite, and Dow Jones futures are...
🔴 Neurosense Therapeutics is trading 14% down today following 1-for-20 reverse stock split
Neurosense Therapeutics is trading 14.01% down now at $6.04 after heightened volatility following its 1-for-20 reverse stock split, effective September 14,...
🔴 Neurosense Therapeutics is trading 6.4% down today after 1-for-20 reverse stock split
Neurosense Therapeutics is trading 6.4% down at $6.58 amid a broader biotech selloff. - The XBI is down 2.11% during the September 16, 2026 session; decline...
🟢 Neurosense Therapeutics is trading 5% up today after 1-for-20 reverse stock split
Neurosense Therapeutics is trading 5.26% up now at $7.40 following extreme volatility after its 1-for-20 reverse stock split, effective September 14, 2026. -...
🔴 Neurosense Therapeutics is trading 10.24% down in pre-market after its 1-for-20 reverse stock split
Neurosense Therapeutics is trading 10.24% down now at $6.31 after a highly volatile session following its 1-for-20 reverse stock split, effective September 14,...
🟢 Neurosense Therapeutics is trading 10.77% up today amid volatility after reverse stock split
Neurosense Therapeutics is trading 10.77% up now at $6.89, with gains appearing primarily technical and highly volatile after its 1-for-20 reverse stock...
🔴 Neurosense Therapeutics is trading 8.86% down today after its 1-for-20 reverse stock split took effect
Neurosense Therapeutics is trading 8.86% down now at $6.11 after its 1-for-20 reverse stock split became effective September 14, 2026. - Nasdaq confirmed the...
🔴 Neurosense Therapeutics is trading 10.47% down today after announcing a 1-for-20 reverse share split
Neurosense Therapeutics is trading 10.47% down now at $0.36, with its company-specific reverse split the clearest explanation for the decline. - The...
🔴 Neurosense Therapeutics is trading 7.78% down today after announcing a 1-for-20 reverse share split
Neurosense Therapeutics is trading at $0.37, down 7.78%, after announcing a 1-for-20 reverse share split on September 9, 2026. • The reverse split is likely...
🔴 Neurosense Therapeutics is trading 10.22% down in pre-market after announcing 1-for-20 reverse share split
Neurosense Therapeutics is trading 10.22% down in pre-market at $0.36 after announcing a 1-for-20 reverse share split on September 9, 2026. • The...
NeuroSense Slashes Its Share Count by 95% to Dodge Delisting — But Can a Stock Split Save a Company Running on Fumes?
Shares tumbled 10.2% to $0.36 after NeuroSense Therapeutics announced a 1-for-20 reverse stock split — a move that combines every 20 existing shares into one —...
🔴 Neurosense Therapeutics is trading 10.2% down in after-hours trading after announcing 1-for-20 reverse share split
Neurosense Therapeutics is trading 10.2% down now at $0.36 after announcing a 1-for-20 reverse share split. - It closed at $0.40 on September 9, 2026. - The...
🟢 Neurosense Therapeutics is trading 7.63% up today with no clear company-specific catalyst
Neurosense Therapeutics is trading 7.63% higher at $0.45 after rebounding from its September 8 close of $0.42, with no clear company-specific announcement...
🟢 Neurosense Therapeutics is trading 7.63% up in after-hours trading amid volatility following September 4 gain
Neurosense Therapeutics is trading 7.63% up at $0.45, apparently amid continued volatility following the September 4 gain, with no clear company-specific...